Cardiac biomarker CR represents the deepest level of cardiac biochemical recovery in AL amyloidosis and is associated with survival similar to the general population. Despite biochemical recovery, structural cardiac abnormalities may persist, underscoring the importance of early diagnosis and timely therapy.
Muchtar et al. (Wed,) studied this question.